ciprofloxacin has been researched along with pd 131628 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzard, D; Di Cesare, P; Essiz, M; Fung-Tomc, J; Jacquet, JP; Kessler, RE; Ledoussal, B; Remuzon, P | 1 |
| Andrews, JM; Cooper, MA; Wise, R | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Jabarit-Aldighieri, N; Raoult, D; Torres, H | 1 |
| Forstall, GJ; Knapp, CC; Washington, JA | 1 |
| Cohen, MA; Domagala, JM; Heifetz, CL; Huband, MD; Mailloux, GB; Roland, GE; Yoder, SL | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Pfaller, MA | 1 |
| Bauernfeind, A | 1 |
| Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Cipriani, P; Filadoro, F; Giordano, A; Magni, A; Papa, F | 1 |
| Cohen, MA; Huband, MD | 1 |
14 other study(ies) available for ciprofloxacin and pd 131628
| Article | Year |
|---|---|
Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Mice; Naphthyridines; Structure-Activity Relationship | 1992 |
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ceftazidime; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Imipenem; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Neisseria; Protein Binding; Quinolones | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1992 |
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Rickettsia; Rickettsia rickettsii; Viral Plaque Assay | 1992 |
Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus | 1991 |
In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines | 1991 |
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Staphylococcus; Staphylococcus aureus | 1991 |
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines | 1991 |
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |
Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Naphthyridines | 1994 |
Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Xanthomonas | 1994 |
Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carbapenems; Cell Membrane; Ciprofloxacin; Fluoroquinolones; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1995 |
In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma hominis; Mycoplasma pneumoniae; Naphthyridines; Quinolones; Tetracycline; Ureaplasma urealyticum | 1997 |